DK1330656T3 - Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf - Google Patents

Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf

Info

Publication number
DK1330656T3
DK1330656T3 DK01992896T DK01992896T DK1330656T3 DK 1330656 T3 DK1330656 T3 DK 1330656T3 DK 01992896 T DK01992896 T DK 01992896T DK 01992896 T DK01992896 T DK 01992896T DK 1330656 T3 DK1330656 T3 DK 1330656T3
Authority
DK
Denmark
Prior art keywords
app
applications
app protein
detecting pathological
detecting
Prior art date
Application number
DK01992896T
Other languages
English (en)
Inventor
Andre Delacourte
Nicolas Sergeant
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK1330656T3 publication Critical patent/DK1330656T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01992896T 2000-11-03 2001-11-05 Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf DK1330656T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0014143A FR2816411B1 (fr) 2000-11-03 2000-11-03 Moyens de detection de la transformation pathologique de la proteine app et leurs applications
PCT/FR2001/003410 WO2002037118A1 (fr) 2000-11-03 2001-11-05 Moyens de detection de la transformation pathologique de la proteine app et leurs applications

Publications (1)

Publication Number Publication Date
DK1330656T3 true DK1330656T3 (da) 2008-08-11

Family

ID=8856055

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01992896T DK1330656T3 (da) 2000-11-03 2001-11-05 Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf

Country Status (13)

Country Link
US (1) US7723117B2 (da)
EP (1) EP1330656B1 (da)
JP (1) JP4294953B2 (da)
AT (1) ATE392620T1 (da)
AU (2) AU2002223743B2 (da)
CA (1) CA2427604A1 (da)
CY (1) CY1108182T1 (da)
DE (1) DE60133661T2 (da)
DK (1) DK1330656T3 (da)
ES (1) ES2305126T3 (da)
FR (1) FR2816411B1 (da)
PT (1) PT1330656E (da)
WO (1) WO2002037118A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7598049B2 (en) * 2003-11-19 2009-10-06 Satoris, Inc. Methods for diagnosis of Alzheimer's Disease in blood samples
US20060094064A1 (en) * 2003-11-19 2006-05-04 Sandip Ray Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
CA2585983C (en) 2004-11-10 2014-03-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
US20090099062A1 (en) * 2007-05-31 2009-04-16 Ethan Lee Pyrvinium For The Treatment of Cancer
DE202007015863U1 (de) * 2007-11-12 2009-03-26 Melitta Haushaltsprodukte Gmbh & Co. Kommanditgesellschaft Filterpapiereinsatz
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
EP2513062A1 (en) 2009-12-16 2012-10-24 Institut National de la Santé et de la Recherche Médicale 7-chloro-quinolin-4-amine compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
EP2596132A4 (en) 2010-07-23 2013-12-18 Harvard College METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS
US20130096552A1 (en) * 2011-10-14 2013-04-18 Christopher L. Brace Hydrodissection Material with Reduced Migration
MX2014015434A (es) 2012-06-15 2015-07-14 Harry Stylli Metodos para detectar enfermedades o condiciones utilizando celulas enfermas en circulacion.
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
BR112015024234B1 (pt) 2013-03-21 2022-11-16 Eupraxia Pharmaceuticals USA LLC Composição farmacêutica de liberação sustentada injetável, uso da mesma para diminuir inflamação ou controlar dor e método para formar micropartículas revestidas
DK3206672T3 (da) 2015-10-27 2018-06-18 Eupraxia Pharmaceuticals Inc Formuleringer til vedvarende frigivelse af lokalbedøvelsesmidler
US11397188B2 (en) * 2017-03-30 2022-07-26 Board Of Regents, The University Of Texas System Method of detecting an APP Alzheimer's disease marker peptide in patients with Alzheimer's disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
WO1992000521A1 (en) * 1990-06-29 1992-01-09 Case Western Reserve University Diagnostic and prognostic methods based on soluble derivatives of the beta amyloid protein precursor
CA2086165A1 (en) * 1992-04-09 1993-10-10 Paul P. Tamburini Diagnostic assay for alzheimer's disease based on the proteolysis of alzheimer's precursor protein
US5441870A (en) * 1992-04-15 1995-08-15 Athena Neurosciences, Inc. Methods for monitoring cellular processing of β-amyloid precursor protein
WO1994007144A1 (en) * 1992-09-21 1994-03-31 United States Of America, As Represented By The Secretary, Department Of Health And Human Services A method of screening compounds and methods for treating alzheimer's disease
US6114133A (en) * 1994-11-14 2000-09-05 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)

Also Published As

Publication number Publication date
EP1330656A1 (fr) 2003-07-30
US7723117B2 (en) 2010-05-25
WO2002037118A1 (fr) 2002-05-10
US20070026527A1 (en) 2007-02-01
JP2004522940A (ja) 2004-07-29
DE60133661T2 (de) 2009-05-28
AU2002223743B2 (en) 2007-01-11
AU2374302A (en) 2002-05-15
EP1330656B1 (fr) 2008-04-16
FR2816411B1 (fr) 2003-07-04
CY1108182T1 (el) 2014-02-12
CA2427604A1 (fr) 2002-05-10
ES2305126T3 (es) 2008-11-01
JP4294953B2 (ja) 2009-07-15
DE60133661D1 (de) 2008-05-29
PT1330656E (pt) 2008-07-24
FR2816411A1 (fr) 2002-05-10
ATE392620T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
DK1330656T3 (da) Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf
CY1112737T1 (el) Ισοτοπικα σεσημασμενες ενωσεις βενζοfuran σαν παραγοντες απεικονισης για πρωτεϊνες δημιουργιας αμυλοειδους (αμυloid)
DK0971033T3 (da) Test og model til Alzheimers sygdom
DK1155325T3 (da) Fremgangsmåde til diagnosticering af og skelnen mellem typer af slagtilfælde
NO20075671L (no) Neurodegenerative markorer for psykiatriske tilstander
DK1625403T3 (da) Fremgasngsmåde til forudsigelsen, diagnosen og differentialdiagnosen af Alzheimers sygdom
DK1594833T3 (da) 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme
FR2810739B1 (fr) Immunodosage electrochimiques a l'aide de marqueurs metalliques colloidaux
EP2251695A3 (en) Markers associated with endometrial disease
WO2001087354A3 (en) Use of small molecule radioligands for diagnostic imaging
DK2172208T3 (da) Små peptider til behandling af alzheimers sygdom og andre beta-amyloidprotein- fibrillogeneseforstyrrelser
EP0660700A4 (fr) Procede de deformation permanente des matieres keratiniques.
HUP0301812A2 (hu) Átvizsgálási (screening) eljárás
ATE417930T1 (de) Proteinkinase npk-110
DE69913325D1 (de) Nephrin gen und protein
DE10343826A1 (de) Knochenfester Lokator und optisches Navigaionssystem
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
DK1639139T3 (da) Fremgangsmåder til påvisning af Alzheimers sygdom
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.
AU2003235113A8 (en) Method of measuring neprilysin activity
WO2006089422A8 (en) Protein and its use in diagnosing alzheimer's disease
RU2003109208A (ru) Способ определения механической твёрдости хрусталика
DE59914764D1 (de) Diagnostischer Kit
ITRM20000693A0 (it) Procedimento per la determinazione quantitativa dello iodio in fluidibiologici, e apparato semiautomatico per la sua attuazione.
Ildikó Analysis of bacterial proteins by capillary electrophoresis